Fullerton Health China Completes the Acquisition of a Majority Stake in Global Doctor

[vc_row][vc_column][vc_column_text][wp-dt-custom init=”post-created” format=”d F Y”][/vc_column_text][vc_column_text]Shanghai, May 7, 2018 – Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”), a leading managed care provider in Asia Pacific, announced today that Fullerton Health China Limited (“Fullerton China”) has completed the acquisition of a majority stake of Jiangsu Kangruijia Medical Investment Management Co., Ltd and its subsidiaries (“Global Doctor”).

Global Doctor, founded in 1999, is one of the largest primary care clinic groups in China with 18 clinics in Nanjing, Chongqing, Chengdu, Dongguan, Guangzhou, Nanchang and Suzhou. The company has a strong reputation for providing quality healthcare services and is supported by experienced multi-lingual medical staff and a broad range of diagnostic and treatment modalities.

Following the RMB 800 million investment into Fullerton Health by Ping An Capital Co., Ltd announced in November last year, Global Doctor is the first investment of Fullerton Health in China. The acquisition is aligned with Fullerton Health’s strategy of developing a strong presence in China, and allows it to extend its reach to corporate clients beyond the core target markets of Shanghai and Beijing.

Dr. Daniel Chan, President, Fullerton China commented: “I am thrilled to welcome the Global Doctor team to join Fullerton Health today. With the deepening of China’s healthcare reform, there is no better time for Fullerton Health to expand into the Chinese market. As a leading provider of corporate healthcare solutions in the Asia Pacific region with a proven track record, Fullerton Health is uniquely positioned to offer quality healthcare that is affordable and accessible in China. This is an important acquisition for us and is strategically aligned with Fullerton Health’s expansion plan in China. We look forward to working closely together with Global Doctor to other cities, including Wuhan and Xian.”

Gao Yunhu, Managing Director, Global Doctor said, “The investment by Fullerton Health, establishing themselves as our majority shareholder, is an exciting development for Global Doctor. The acquisition enables Global Doctor to tap into Fullerton Health’s expansive network and wealth of experience across 8 geographies in Asia Pacific, further enhancing our operations and ability to provide quality clinical care in China. With strong track record and its position as the pre-eminent corporate healthcare services provider across Asia Pacific, Fullerton Health is the ideal partner for Global Doctor as we embark on the next stage of our development.”[/vc_column_text][/vc_column][/vc_row]

Share it in your Social Media

Share on facebook
Share on twitter
Share on linkedin

We use cookies to ensure that we give you the best experience on our website. By continuing, you are agreeing to our Privacy Policy. To decline cookies, modify your browser settings at any time.